These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16267035

  • 1. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.
    Dubé N, Bourdeau A, Heinonen KM, Cheng A, Loy AL, Tremblay ML.
    Cancer Res; 2005 Nov 01; 65(21):10088-95. PubMed ID: 16267035
    [Abstract] [Full Text] [Related]

  • 2. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D, Thomas-Tikhonenko A.
    Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625
    [Abstract] [Full Text] [Related]

  • 3. The role of protein tyrosine phosphatase 1B in Ras signaling.
    Dubé N, Cheng A, Tremblay ML.
    Proc Natl Acad Sci U S A; 2004 Feb 17; 101(7):1834-9. PubMed ID: 14766979
    [Abstract] [Full Text] [Related]

  • 4. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
    Bentires-Alj M, Neel BG.
    Cancer Res; 2007 Mar 15; 67(6):2420-4. PubMed ID: 17347513
    [Abstract] [Full Text] [Related]

  • 5. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.
    Julien SG, Dubé N, Read M, Penney J, Paquet M, Han Y, Kennedy BP, Muller WJ, Tremblay ML.
    Nat Genet; 2007 Mar 15; 39(3):338-46. PubMed ID: 17259984
    [Abstract] [Full Text] [Related]

  • 6. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
    Backlund MG, Trasti SL, Backlund DC, Cressman VL, Godfrey V, Koller BH.
    Cancer Res; 2001 Sep 01; 61(17):6577-82. PubMed ID: 11522657
    [Abstract] [Full Text] [Related]

  • 7. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.
    Joliat MJ, Lang PA, Lyons BL, Burzenski L, Lynes MA, Yi T, Sundberg JP, Shultz LD.
    J Autoimmun; 2002 Mar 01; 18(2):105-17. PubMed ID: 11908943
    [Abstract] [Full Text] [Related]

  • 8. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
    Vanasse GJ, Halbrook J, Thomas S, Burgess A, Hoekstra MF, Disteche CM, Willerford DM.
    J Clin Invest; 1999 Jun 01; 103(12):1669-75. PubMed ID: 10377173
    [Abstract] [Full Text] [Related]

  • 9. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F, Mena P, Fingerle-Rowson G, Moll U, Petrenko O.
    Cell Death Differ; 2005 Oct 01; 12(10):1319-28. PubMed ID: 15947793
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
    Pamidi A, Cardoso R, Hakem A, Matysiak-Zablocki E, Poonepalli A, Tamblyn L, Perez-Ordonez B, Hande MP, Sanchez O, Hakem R.
    Cancer Res; 2007 Sep 15; 67(18):8527-35. PubMed ID: 17875692
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M, Fernández-Veledo S, Vila-Bedmar R, Garcia-Guerra L, De Alvaro C, Nieto-Vazquez I.
    J Anim Sci; 2008 Apr 15; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S, Fantus IG.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec 15; 21(4):621-40. PubMed ID: 18054739
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
    Ward JM, Tadesse-Heath L, Perkins SN, Chattopadhyay SK, Hursting SD, Morse HC.
    Lab Invest; 1999 Jan 15; 79(1):3-14. PubMed ID: 9952106
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Establishment of a cell-based drug screening model for identifying down-regulators of Protein Tyrosine Phosphatase 1B expression.
    Lian JH, Guo L, Hu WR, Wu GL, Ji W, Gong BQ.
    Exp Clin Endocrinol Diabetes; 2007 Jan 15; 115(1):24-8. PubMed ID: 17286230
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.